MB Therapeutics is a startup located at the Faculty of Pharmacy in Montpellier. Specializing in personalized medicine and 3D printing technology, the company aims to improve drug administration. They are currently in the process of recruiting three engineers to join the team of two doctors. Patients who are especially close to the hearts of these two young fathers: Children with heart diseases.
Founded in 2015, Triastek, Inc. is the global leader in the 3D printing of pharmaceuticals and is pioneering the implementation of digital pharmaceutical solutions. Triastek’s novel and proprietary 3D printing technology platform, encompasses dosage form design, digital pharmaceutical product development, and intelligent manufacturing.
Our purpose is to solve the toughest problems in life science by collaborating with the global scientific community – and through that, we aim to accelerate access to better health for people everywhere. We provide scientists and engineers with best-in-class lab materials, technologies and services. With the 2015 combination of Merck Millipore and Sigma-Aldrich, we now have a broad portfolio of 300,000 products and an expanded global footprint.